Tumour necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families

Genes and Immunity

Volumn 2, Issue 2, 2001, Pages 82-87

  Waldron Lynch, F ^a,e   Adams, C ^a   Amos, C ^b   Zhu, D K ^b   McDermott, M F ^c   Shanahan, F ^d   Molloy, M G ^d   O'Gara, F ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF TEXAS   (United States)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d University College Cork and INFANT Centre   (Ireland)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autoimmunity; Immunogenetics; Single nucleotide polymorphisms; Transmission disequilibrium test

Indexed keywords

HLA DR ANTIGEN; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; PROMOTER REGION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035317378     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363738     Document Type: Article

References (48)

1. Ollier WER, MacGregor A. Genetic epidemiology of rheumatoid disease. Br Med Bulletin 1995; 51: 267-285.
2. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
3. Maini RN. The role of cytokines in rheumatoid arthritis. J Royal Coll Physic Lon 1996; 30: 344-351.
4. Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis. Arthritis Rheum 1997; 40: 5-18.
5. Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinase to treat arthritis. Arthritis Rheum 1994; 37: 1115-1126.
6. Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10: 4025-1031.
7. Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. TNFα is an effective therapeutic target in rheumatoid arthritis. Annals New York Acad Sci 1995; 766: 272-278.
8. Elliott MJ, Maini RN, Feldmann M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α. Lancet 1994; 344: 1105-1110.
9. Moreland LW, Baumgartner SW, Schiff MH et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997; 3: 141-147.
10. Seldin MF, Amos CI, Ward R, Gregresen PF. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999; 42: 1071-1079.
11. Cornelis F, Faure S, Martinez M et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998; 95: 10746-10750.
12. Wordsworth P. Genes and arthritis. Br Med Bull 1995; 51: 249-266.
13. Nepom GT, Nepom BS. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum Dis Clin North Am 1992; 18: 785-792.
14. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. Arthritis Rheum 1987; 30: 1205-1213.
15. Genin E, Babron MC, McDermott MF et al. Modelling the major histocompatibility complex susceptibility to RA using the MASC method. Genet Epidemiol 1998; 15: 419-430.
16. Mulcahy B, Waldron-Lynch F, Mc Dermott MF et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996; 59: 676-683.
17. Mu Hua, Chen JJ, Jiang Y, King MC, Thomson G, Criswell LA. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum 1999; 42: 438-442.
18. Ruuls SR, Sedgwick JD. Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models. Am J Hum Genet 1999; 65: 294-301.
19. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16: 180-186.
20. Hajeer AH, Worthington J, Silman AJ, Ollier WE. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DR B1*-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996; 39: 1109-1114.
21. Bali D, Gourley S, Kostyu DD et al. Genetic analysis of multiplex rheumatoid arthritis families. Genes Immun 1999; 1: 28-36.
22. Aggarwal BB, Natarasjan K. Tumor necrosis factors: development during the last decade. Eur Cytokine Netw 1996; 7: 93-124.
23. Waldron-Lynch F, Adams C, Shanahan F, Molloy MG, O'Gara F. Genetic analysis of the 3′ untranslated region of the tumor necrosis factor shows a highly conserved region in rheumatoid arthritis affected and unaffected subjects. J Med Genet 1999; 36: 214-216.
24. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51: 605-612.
25. Hamann A, Mantzoros C, Vidual-Puig A, Flier JS. Genetic variability in the TNF promoter is not associated with type II diabetes Mellitus. Biochem Biophy Res Com 1995; 211: 833-839
26. Uglialoro AM, Turbay D, Pesavento PA et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359-367.
27. Wilson AG, De Vries N, Pociot F, Giovine FS, Van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177:557-560.
28. Brinkman BMN, Kaijzel EL, Huizinga TWJ, Giphart MJ, Breedveld FC, Verweij CL. Detection of a C-insertion polymorphism within the human tumor necrosis factor alpha (TNFα) gene. Hum Genet 1995; 96: 493.
29. Knight JC, Udalova I, Hill AVS et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
30. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
31. Kroger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
32. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis (TNFα) -308 promoter polymorphism in TNFa gene regulation. J Inflamm 1996; 46: 32-41.
33. Studer F, Udalova IA, Book M et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducability of the human TNF promoter. J Inflamm 1995; 46: 42-50.
34. Skoog T, Ferdinand M. van't Hooft et al. A common functional polymorphism (C/A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene is associated with reduced circulating levels of TNF-α. Hum Mol Genet 1999; 8: 1443-1449.
35. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulindependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
36. Self SG, Longton G, Kopecky KJ, Liang KY. On estimating HLA/disease association with application to a study of aplastic anemia. Biometrics 1991; 47: 53-61.
37. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146-154.
38. Wilson AG, De Vries N, Van de Putte LBA, Duff GW. A tumour necrosis factor α polymorphism is not associated with rheumatoid arthritis. Annals Rheum Dis 1995; 54: 601-603.
39. Browning JL, Ngam-ek A, Lawton P et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993; 72: 847-856.
40. De Baey A, Holzinger I, Scholz S, Keller E, Weiss EH Albert E. Pvu II polymorphism in the primate homologue of mouse B144 (LST-1) a novel marker gene within the tumor necrosis factor region. Hum Immun 1995; 42: 9-14.
41. Kaijazel EL, van Krugten MV, Brinkman BM et al. Functional analysis of the human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998; 4: 724-733.
42. Brinkman BMN, Huizinga TWJ, Kurban SS et al. Tumour necrosis factor α gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumat 1997; 36: 516-521.
43. Goldfeld AE, Strominger JL, Doyle C. Human tumor necrosis factor a gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med 1991; 174: 73-81.
44. Trede NS, Tsytsykova AV, Chatila T, Goldfield AE, Geha RS. Transcriptional activation of the human TNF α promoter by superantigen in human monocytic cells. J Immunol 1995; 155: 902-908.
45. Rhoades KL, Golub SH, Economou JS. The regulation of the human tumour necrosis factor α promoter region in macrophage, T cell, and B cell lines. J Biol Chem 1992; 267: 22102-22107.
46. Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Totoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996; 110: 1053-1060
47. Arnett F C, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
48. Worthington J, Ollier WER, Leach Mk et al. The Arthritis and Rheumatism Council's National Repository of family material: pedigrees from the first 100 rheumatoid arthritis families containing affected sibling pairs. Br J Rheum 1994; 33: 970-976.